General Information of Drug (ID: DMC92DQ)

Drug Name
TAUTOMYCIN Drug Info
Synonyms
Tautomycin; AC1L99OL; CHEBI:9414; CHEMBL505512; CTK8E8541; 109946-35-2; Tautomycin from Streptomyces spiroverticillatus; SCHEMBL83891; DNC014580; BDBM50366883; RT-015883; C05372; J-002353; [(1R,2R,3R,6S,7S,10R)-10-[(2S,3S,6R,8S,9R)-3,9-dimethyl-8-[(3S)-3-methyl-4-oxo-pentyl]-1,7-dioxaspiro[5.5]undecan-2-yl]-3,7-dihydroxy-1-isopropyl-2-methoxy-6-methyl-5-oxo-undecyl] (3R)-3-hydroxy-3-(4-methyl-2,5-dioxo-3-furyl)propanoate
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
440646
ChEBI ID
CHEBI:9414
TTD Drug ID
DMC92DQ

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cantharidin DMBP5N3 Molluscum contagiosum infection 1E76 Approved [1]
NORCANTHARIDIN DM9B6Y1 Discovery agent N.A. Investigative [2]
PALASONIN DMDTP1R Discovery agent N.A. Investigative [1]
CANTHARIDIC_ACID DME32XU Discovery agent N.A. Investigative [1]
MICROCYSTIN-LR DMTMLRN Discovery agent N.A. Investigative [1]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Serine/threonine PP1-alpha (PPP1CA) TTFLH0E PP1A_HUMAN Inhibitor [1]

References

1 Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies. J Med Chem. 2002 Mar 14;45(6):1151-75.
2 In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2). Bioorg Med Chem Lett. 2010 Dec 15;20(24):7331-6.